Atorvastatin for myelodysplastic syndromes

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Aug 2022: Trial registered, NCT05483010
  2. 19 Feb 2024: Trial started, NCT05483010

The trials

NCT05483010: Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS)

State
Under way
Phase
Phase 2
People
16 planned
Started
19 Feb 2024
Primary completion
31 May 2028
Arms
Atorvastatin
Results
None posted
  1. 1 Aug 2022: Trial registered
  2. 19 Feb 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.